2h64

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
(New page: 200px<br /> <applet load="2h64" size="450" color="white" frame="true" align="right" spinBox="true" caption="2h64, resolution 1.92&Aring;" /> '''Crystal structure o...)
Line 1: Line 1:
-
[[Image:2h64.gif|left|200px]]<br />
+
[[Image:2h64.gif|left|200px]]<br /><applet load="2h64" size="350" color="white" frame="true" align="right" spinBox="true"
-
<applet load="2h64" size="450" color="white" frame="true" align="right" spinBox="true"
+
caption="2h64, resolution 1.92&Aring;" />
caption="2h64, resolution 1.92&Aring;" />
'''Crystal structure of a ternary ligand-receptor complex of BMP-2'''<br />
'''Crystal structure of a ternary ligand-receptor complex of BMP-2'''<br />
==Overview==
==Overview==
-
BACKGROUND: Bone morphogenetic proteins (BMPs) are key regulators in the, embryonic development and postnatal tissue homeostasis in all animals., Loss of function or dysregulation of BMPs results in severe diseases or, even lethality. Like transforming growth factors beta (TGF-betas), activins, growth and differentiation factors (GDFs) and other members of, the TGF-beta superfamily, BMPs signal by assembling two types of, serine/threonine-kinase receptor chains to form a hetero-oligomeric, ligand-receptor complex. BMP ligand receptor interaction is highly, promiscuous, i.e. BMPs bind more than one receptor of each subtype, and a, receptor bind various ligands. The activin type II receptors are of, particular interest, since they bind a large number of diverse ligands. In, addition they act as high-affinity receptors for activins but are also, low-affinity receptors for BMPs. ActR-II and ActR-IIB therefore represent, an interesting example how affinity and specificity might be generated in, a promiscuous background. RESULTS: Here we present the high-resolution, structures of the ternary complexes of wildtype and a variant BMP-2 bound, to its high-affinity type I receptor BMPR-IA and its low-affinity type II, receptor ActR-IIB and compare them with the known structures of binary and, ternary ligand-receptor complexes of BMP-2. In contrast to activin or, TGF-beta3 no changes in the dimer architecture of the BMP-2 ligand occur, upon complex formation. Functional analysis of the ActR-IIB binding, epitope shows that hydrophobic interactions dominate in low-affinity, binding of BMPs; polar interactions contribute only little to binding, affinity. However, a conserved H-bond in the center of the type II, ligand-receptor interface, which does not contribute to binding in the, BMP-2 - ActR-IIB interaction can be mutationally activated resulting in a, BMP-2 variant with high-affinity for ActR-IIB. Further mutagenesis studies, were performed to elucidate the binding mechanism allowing us to construct, BMP-2 variants with defined type II receptor binding properties., CONCLUSION: Binding specificity of BMP-2 for its three type II receptors, BMPR-II, Act-RII and ActR-IIB is encoded on single amino acid level., Exchange of only one or two residues results in BMP-2 variants with a, dramatically altered type II receptor specificity profile, possibly, allowing construction of BMP-2 variants that address a single type II, receptor. The structure-/function studies presented here revealed a new, mechanism, in which the energy contribution of a conserved H-bond is, modulated by surrounding intramolecular interactions to achieve a switch, between low- and high-affinity binding.
+
BACKGROUND: Bone morphogenetic proteins (BMPs) are key regulators in the embryonic development and postnatal tissue homeostasis in all animals. Loss of function or dysregulation of BMPs results in severe diseases or even lethality. Like transforming growth factors beta (TGF-betas), activins, growth and differentiation factors (GDFs) and other members of the TGF-beta superfamily, BMPs signal by assembling two types of serine/threonine-kinase receptor chains to form a hetero-oligomeric ligand-receptor complex. BMP ligand receptor interaction is highly promiscuous, i.e. BMPs bind more than one receptor of each subtype, and a receptor bind various ligands. The activin type II receptors are of particular interest, since they bind a large number of diverse ligands. In addition they act as high-affinity receptors for activins but are also low-affinity receptors for BMPs. ActR-II and ActR-IIB therefore represent an interesting example how affinity and specificity might be generated in a promiscuous background. RESULTS: Here we present the high-resolution structures of the ternary complexes of wildtype and a variant BMP-2 bound to its high-affinity type I receptor BMPR-IA and its low-affinity type II receptor ActR-IIB and compare them with the known structures of binary and ternary ligand-receptor complexes of BMP-2. In contrast to activin or TGF-beta3 no changes in the dimer architecture of the BMP-2 ligand occur upon complex formation. Functional analysis of the ActR-IIB binding epitope shows that hydrophobic interactions dominate in low-affinity binding of BMPs; polar interactions contribute only little to binding affinity. However, a conserved H-bond in the center of the type II ligand-receptor interface, which does not contribute to binding in the BMP-2 - ActR-IIB interaction can be mutationally activated resulting in a BMP-2 variant with high-affinity for ActR-IIB. Further mutagenesis studies were performed to elucidate the binding mechanism allowing us to construct BMP-2 variants with defined type II receptor binding properties. CONCLUSION: Binding specificity of BMP-2 for its three type II receptors BMPR-II, Act-RII and ActR-IIB is encoded on single amino acid level. Exchange of only one or two residues results in BMP-2 variants with a dramatically altered type II receptor specificity profile, possibly allowing construction of BMP-2 variants that address a single type II receptor. The structure-/function studies presented here revealed a new mechanism, in which the energy contribution of a conserved H-bond is modulated by surrounding intramolecular interactions to achieve a switch between low- and high-affinity binding.
==Disease==
==Disease==
-
Known diseases associated with this structure: Cowden-like syndrome OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=601299 601299]], Juvenile polyposis syndrome, infantile form OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=601299 601299]], Polyposis syndrome, hereditary mixed, 2 OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=601299 601299]], Polyposis, juvenile intestinal OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=601299 601299]]
+
Known diseases associated with this structure: HFE hemochromatosis, modifier of OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=112261 112261]], Juvenile polyposis syndrome, infantile form OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=601299 601299]], Polyposis syndrome, hereditary mixed, 2 OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=601299 601299]], Polyposis, juvenile intestinal OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=601299 601299]]
==About this Structure==
==About this Structure==
-
2H64 is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] and [http://en.wikipedia.org/wiki/Mus_musculus Mus musculus]. Active as [http://en.wikipedia.org/wiki/Receptor_protein_serine/threonine_kinase Receptor protein serine/threonine kinase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.7.11.30 2.7.11.30] Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=2H64 OCA].
+
2H64 is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] and [http://en.wikipedia.org/wiki/Mus_musculus Mus musculus]. Active as [http://en.wikipedia.org/wiki/Receptor_protein_serine/threonine_kinase Receptor protein serine/threonine kinase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.7.11.30 2.7.11.30] Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2H64 OCA].
==Reference==
==Reference==
Line 19: Line 18:
[[Category: Protein complex]]
[[Category: Protein complex]]
[[Category: Receptor protein serine/threonine kinase]]
[[Category: Receptor protein serine/threonine kinase]]
-
[[Category: Mueller, T.D.]]
+
[[Category: Mueller, T D.]]
[[Category: Sebald, W.]]
[[Category: Sebald, W.]]
[[Category: Weber, D.]]
[[Category: Weber, D.]]
Line 25: Line 24:
[[Category: tgf-beta superfamily]]
[[Category: tgf-beta superfamily]]
-
''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Mon Nov 12 22:27:17 2007''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 17:38:32 2008''

Revision as of 15:38, 21 February 2008


2h64, resolution 1.92Å

Drag the structure with the mouse to rotate

Crystal structure of a ternary ligand-receptor complex of BMP-2

Contents

Overview

BACKGROUND: Bone morphogenetic proteins (BMPs) are key regulators in the embryonic development and postnatal tissue homeostasis in all animals. Loss of function or dysregulation of BMPs results in severe diseases or even lethality. Like transforming growth factors beta (TGF-betas), activins, growth and differentiation factors (GDFs) and other members of the TGF-beta superfamily, BMPs signal by assembling two types of serine/threonine-kinase receptor chains to form a hetero-oligomeric ligand-receptor complex. BMP ligand receptor interaction is highly promiscuous, i.e. BMPs bind more than one receptor of each subtype, and a receptor bind various ligands. The activin type II receptors are of particular interest, since they bind a large number of diverse ligands. In addition they act as high-affinity receptors for activins but are also low-affinity receptors for BMPs. ActR-II and ActR-IIB therefore represent an interesting example how affinity and specificity might be generated in a promiscuous background. RESULTS: Here we present the high-resolution structures of the ternary complexes of wildtype and a variant BMP-2 bound to its high-affinity type I receptor BMPR-IA and its low-affinity type II receptor ActR-IIB and compare them with the known structures of binary and ternary ligand-receptor complexes of BMP-2. In contrast to activin or TGF-beta3 no changes in the dimer architecture of the BMP-2 ligand occur upon complex formation. Functional analysis of the ActR-IIB binding epitope shows that hydrophobic interactions dominate in low-affinity binding of BMPs; polar interactions contribute only little to binding affinity. However, a conserved H-bond in the center of the type II ligand-receptor interface, which does not contribute to binding in the BMP-2 - ActR-IIB interaction can be mutationally activated resulting in a BMP-2 variant with high-affinity for ActR-IIB. Further mutagenesis studies were performed to elucidate the binding mechanism allowing us to construct BMP-2 variants with defined type II receptor binding properties. CONCLUSION: Binding specificity of BMP-2 for its three type II receptors BMPR-II, Act-RII and ActR-IIB is encoded on single amino acid level. Exchange of only one or two residues results in BMP-2 variants with a dramatically altered type II receptor specificity profile, possibly allowing construction of BMP-2 variants that address a single type II receptor. The structure-/function studies presented here revealed a new mechanism, in which the energy contribution of a conserved H-bond is modulated by surrounding intramolecular interactions to achieve a switch between low- and high-affinity binding.

Disease

Known diseases associated with this structure: HFE hemochromatosis, modifier of OMIM:[112261], Juvenile polyposis syndrome, infantile form OMIM:[601299], Polyposis syndrome, hereditary mixed, 2 OMIM:[601299], Polyposis, juvenile intestinal OMIM:[601299]

About this Structure

2H64 is a Protein complex structure of sequences from Homo sapiens and Mus musculus. Active as Receptor protein serine/threonine kinase, with EC number 2.7.11.30 Full crystallographic information is available from OCA.

Reference

A silent H-bond can be mutationally activated for high-affinity interaction of BMP-2 and activin type IIB receptor., Weber D, Kotzsch A, Nickel J, Harth S, Seher A, Mueller U, Sebald W, Mueller TD, BMC Struct Biol. 2007 Feb 12;7:6. PMID:17295905

Page seeded by OCA on Thu Feb 21 17:38:32 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools